According to Bayer Healthcare’s Annual Financial Report, the company has agreed to settle lawsuits brought by 70 women over serious injuries caused by the birth control pill Yaz. The company is still facing nearly 11,300 additional lawsuits over Yaz and Yasmin.
The birth control drugs contain the progestin drospirenone, which according to the FDA put women at much higher risk of blood clots then older birth control pills. Several studies have indicated Yaz, Yasmin and a third variation of the drugs, Beyaz, cause an increased risk of blood clots, deep vein thrombosis, pulmonary embolism, stroke, and sudden death. The drugs also double the risk of heart attack and stroke to women just starting birth control, with some side effects presenting in the first three months of use.
Generic versions of drospirenone-containing birth control include Ocella, Zarah, Syeda, Loryna, Gianvi, and Safyral.
A federal judge presiding over lawsuits filed throughout district courts across the country, which allege the company failed to warn consumers and physicians about the increased risks of blood clots, has ordered Bayer and attorneys for the plaintiffs into settlement negations before the first bellwether trials begin.